This website is intended for healthcare professionals only

Trending Topic

Glucose meter device with test strips and lancets on a blue textured background
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Type 2 diabetes (T2D) is a progressive metabolic condition associated with obesity, cardiovascular disease and substantial morbidity and mortality.1 Despite the availability of multiple glucose-lowering therapies, a significant proportion of individuals with T2D fail to achieve recommended glycemic targets, particularly those with long disease duration, obesity and insulin resistance.2,3 In parallel, excess adiposity remains a major driver of […]

Quentin Anstee, Digital NAFLD Summit 2021: Exciting Advances and New Research into the Management of Non-alcoholic Fatty Liver Disease

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 7th 2021

touchENDOCRINOLOGY joins Prof. Quentin Anstee (Newcastle University, UK) at the Digital NAFLD Summit 2021 to discuss his highlights from the conference and new, exciting developments in the field.

Questions
1. Please summarise the prevalence of non-alcoholic fatty liver disease (NAFLD) and the clinical unmet needs in this area? (0:20)
2. What are the current most exciting advances and new research in this field? (1:00)

Disclosures: Quentin Anstee has no conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed in coverage of the Digital NAFLD Summit 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup